
### [MONDO:0001166](http://purl.obolibrary.org/obo/MONDO_0001166)
**Label:** nephritis

**Subclasses:** [MONDO:0013496](http://purl.obolibrary.org/obo/MONDO_0013496) (IGAN2), [MONDO:0008072](http://purl.obolibrary.org/obo/MONDO_0008072) (IGAN1), [MONDO:0017236](http://purl.obolibrary.org/obo/MONDO_0017236) (rapidly progressive glomerulonephritis), [MONDO:0014786](http://purl.obolibrary.org/obo/MONDO_0014786) (Iga nephropathy, susceptibility to, 3; IGAN3), [MONDO:0014451](http://purl.obolibrary.org/obo/MONDO_0014451) (focal segmental glomerulosclerosis 7), [MONDO:0014462](http://purl.obolibrary.org/obo/MONDO_0014462) (focal segmental glomerulosclerosis 8), [MONDO:0013191](http://purl.obolibrary.org/obo/MONDO_0013191) (focal segmental glomerulosclerosis 5), [MONDO:0011390](http://purl.obolibrary.org/obo/MONDO_0011390) (focal segmental glomerulosclerosis 2), [MONDO:0007416](http://purl.obolibrary.org/obo/MONDO_0007416) (Balkan nephropathy), [MONDO:0011917](http://purl.obolibrary.org/obo/MONDO_0011917) (focal segmental glomerulosclerosis 3, susceptibility to), [MONDO:0012931](http://purl.obolibrary.org/obo/MONDO_0012931) (focal segmental glomerulosclerosis 4, susceptibility to), [MONDO:0011303](http://purl.obolibrary.org/obo/MONDO_0011303) (focal segmental glomerulosclerosis 1), [MONDO:0014539](http://purl.obolibrary.org/obo/MONDO_0014539) (focal segmental glomerulosclerosis 9), [MONDO:0013589](http://purl.obolibrary.org/obo/MONDO_0013589) (focal segmental glomerulosclerosis 6), [MONDO:0013898](http://purl.obolibrary.org/obo/MONDO_0013898) (karyomegalic interstitial nephritis), 

**Corr. equiv. classes:** [OMIM:603278](http://purl.obolibrary.org/obo/OMIM_603278), [OMIM:603965](http://purl.obolibrary.org/obo/OMIM_603965), [Orphanet:401996](http://www.orpha.net/ORDO/Orphanet_401996), [OMIM:607832](http://purl.obolibrary.org/obo/OMIM_607832), [OMIM:616002](http://purl.obolibrary.org/obo/OMIM_616002), [OMIM:614131](http://purl.obolibrary.org/obo/OMIM_614131), [OMIM:616220](http://purl.obolibrary.org/obo/OMIM_616220), [OMIM:616032](http://purl.obolibrary.org/obo/OMIM_616032), [OMIM:612551](http://purl.obolibrary.org/obo/OMIM_612551), [OMIM:613237](http://purl.obolibrary.org/obo/OMIM_613237), [OMIM:613944](http://purl.obolibrary.org/obo/OMIM_613944), [Orphanet:280569](http://www.orpha.net/ORDO/Orphanet_280569), [Orphanet:93213](http://www.orpha.net/ORDO/Orphanet_93213), [OMIM:124100](http://purl.obolibrary.org/obo/OMIM_124100), [OMIM:614817](http://purl.obolibrary.org/obo/OMIM_614817), [OMIM:161950](http://purl.obolibrary.org/obo/OMIM_161950), [OMIM:616818](http://purl.obolibrary.org/obo/OMIM_616818), 

**Class expressions from DL-Learner:**

- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 57.83%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and (not ([HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology))) 56.86%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0003110](http://purl.obolibrary.org/obo/HP_0003110) (Abnormality of urine homeostasis) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 51.97%
- [HP:0000093](http://purl.obolibrary.org/obo/HP_0000093) (Proteinuria) and [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 51.97%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0012211](http://purl.obolibrary.org/obo/HP_0012211) (Abnormal renal physiology) 51.81%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) 51.26%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0011277](http://purl.obolibrary.org/obo/HP_0011277) (Abnormality of the urinary system physiology) 51.26%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 50.38%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and (not ([HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier))) 50.38%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 48.42%
- [HP:0000097](http://purl.obolibrary.org/obo/HP_0000097) (Focal segmental glomerulosclerosis) and [HP:0000100](http://purl.obolibrary.org/obo/HP_0000100) (Nephrotic syndrome) 48.27%
- [HP:0000096](http://purl.obolibrary.org/obo/HP_0000096) (Glomerulosclerosis) 47.43%
- [HP:0012211](http://purl.obolibrary.org/obo/HP_0012211) (Abnormal renal physiology) 42.90%
- [HP:0012622](http://purl.obolibrary.org/obo/HP_0012622) (Chronic kidney disease) 42.37%
- [HP:0011277](http://purl.obolibrary.org/obo/HP_0011277) (Abnormality of the urinary system physiology) 41.12%


